Area of research
Hematology · Cell Biology
Research interest
Research interests include Acute Myeloid Leukemia Research, Microtubule and mitosis dynamics, Cancer Diagnosis and Treatment, and Chronic Myeloid Leukemia Treatments.
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Letter to the editor re: CDX2 expression as a predictive and prognostic biomarker of 5-fluorouracil response in cancer of unknown primary
Etiology of TP53 mutated complex karyotype acute myeloid leukemia
Tumour mutational burden: clinical utility, challenges and emerging improvements
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary
STIL overexpression shortens lifespan and reduces tumor formation in mice
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in <i>RUNX1</i>, <i>GATA2</i>, and <i>DDX41</i>
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
Cancer of unknown primary (CUP) – lokal begrenzt, oligometastatisch und im Kopf-Hals-Bereich
CUP-Syndrom – die neue ESMO-Leitlinie
Protocol for high-throughput electron tomography exemplified on centrioles in primary human plasma cells
Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
Management of a Pregnant ALK-Positive Lung Cancer Patient With Alectinib-Induced Pneumonitis and Bilateral Globus Pallidus Necrosis Postpartum
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3-</i>ITD mutations: results of the SAL MIDOKIT trial
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary
Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice
Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in <i>RUNX1</i>, <i>GATA2</i> and <i>DDX41</i>
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myeloma
Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption
Correction to: Severe Dysbiosis and Specific <i>Haemophilus</i> and <i>Neisseria</i> Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Pathogenese und molekulare Diagnostik der akuten myeloischen Leukämie
<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome